Ventilator-Associated Pneumonia (VAP) Study Shows Reduction of Biofilms Using Antimicrobial Photodynamic Therapy
Links shared publicly online about this topic.
- 248total visits
Ventilator-Associated Pneumonia (VAP) Study Shows Reduction of Biofilms Using Antimicrobial Photodynamic Therapy
Ventilator-associated pneumonia (VAP) is the number one cause of healthcare-associated infections in intensive care unit patients. In the United States, more than one million patients require mechanical ventilation annually, and 10% to 25% of those patients will develop VAP.
View full resource at prweb.com
Most Recently Shared on June 2, 2011 at 10:52 am By:
Ventilator-Associated Pneumonia (VAP) Study Shows Reduction of Biofilms Using Antimicrobial Photodynamic Therapy... http://bit.ly/jnni0E
Advertisement
